NeuralCIM Neuroprotective Therapy
NeuralCIM is a Cuban biotechnology product — a neuroprotective therapy developed by the Center for Molecular Immunology in Havana — used in Cuba's neurological rehabilitation programs for conditions including Alzheimer's disease, stroke recovery, and traumatic brain injury.
A Neuroprotective Therapy from Cuba
NeuralCIM is a recombinant human erythropoietin with reduced sialic acid content, developed by the Center for Molecular Immunology (CIM) in Havana, Cuba. In Cuba's neurological programs, it is used as a neuroprotective agent intended to support neuron survival and reduce neuroinflammation — alongside intensive cognitive and physical rehabilitation.
Developed by Cuba's Center for Molecular Immunology (CIM), a leading biotechnology institution
A modified erythropoietin molecule designed for neuroprotective rather than hematopoietic (blood-producing) action
Used in combination with cognitive rehabilitation, physical therapy, and multidisciplinary care
Administered under medical supervision as part of individualized 4–8 week treatment cycles
Not approved by the US FDA and not available through US healthcare providers
How NeuralCIM Is Designed to Work
Standard erythropoietin (EPO) is a hormone that stimulates red blood cell production. NeuralCIM is a modified form of EPO with reduced sialic acid residues. This modification is designed to reduce its blood-building activity while retaining neuroprotective properties — the goal being to support neuron survival and modulate neuroinflammation without the hematological side effects of standard EPO.
Neuroprotection
Designed to support the survival of neurons under stress — such as in neurodegenerative diseases like Alzheimer's, or after acute injuries like stroke or traumatic brain injury.
Anti-Inflammatory Action
Intended to modulate neuroinflammation — a process implicated in the progression of Alzheimer's disease and other neurological conditions.
Modified EPO Molecule
The reduced sialic acid content is designed to lower hematopoietic (blood-building) activity, separating neuroprotective effects from red blood cell stimulation.
Combination Therapy
In Cuba, NeuralCIM is not used alone — it is part of a comprehensive program combining neuroprotective therapy with intensive cognitive and physical rehabilitation.
Neurological Conditions Addressed with NeuralCIM
In Cuba's neurological rehabilitation programs, NeuralCIM is used as a neuroprotective therapy across a range of neurological conditions. Each program is individualized based on diagnosis, disease stage, and the patient's overall health.
What a NeuralCIM Treatment Cycle Involves
NeuralCIM is administered as part of a structured, individualized treatment program — not as a standalone medication. Each cycle is designed by a multidisciplinary medical team based on the patient's specific condition and needs.
Clinical Evaluation
Neuroimaging (MRI/CT), neuropsychological assessment, medical history review, and consultation with a neurologist to determine program suitability.
Individualized Treatment Plan
A personalized protocol is designed — combining NeuralCIM neuroprotective therapy with cognitive rehabilitation, physical therapy, and supportive care.
Neuroprotective Therapy
NeuralCIM is administered under medical supervision according to the individualized protocol, with continuous monitoring by the medical team.
Intensive Rehabilitation
Daily cognitive training, physical therapy, occupational therapy, and speech-language therapy — typically 4–6 hours per day, 5 days per week.
Multidisciplinary Monitoring
Regular assessments by neurologists, neuropsychologists, and therapists to track progress and adjust the program as needed.
Aftercare & Handover
A structured discharge plan with coordinated handover to the patient's home-country physician and remote follow-up monitoring.
NeuralCIM Is Only Available in Cuba
NeuralCIM is a product of Cuba's biotechnology industry, developed by the Center for Molecular Immunology. It is not approved by the US FDA and is not available through any US healthcare provider. For patients seeking this specific neuroprotective therapy, travel to Cuba is required.
Developed and manufactured in Cuba by the Center for Molecular Immunology (CIM)
Not FDA-approved — not available through US pharmacies, clinics, or hospitals
Accessed through Cuba's international patient services with full travel coordination
Administered only under the supervision of Cuban medical specialists
Part of a comprehensive rehabilitation program — not available as a standalone prescription
From First Inquiry to NeuralCIM Treatment
Contact Us
Share your medical information and diagnosis through our inquiry form or patient coordinators.
Free Evaluation
Our neurology team reviews your medical records — including MRI/CT scans and physician notes — at no cost.
Program Design
If NeuralCIM therapy is suitable, a personalized treatment plan is created for your specific condition.
Travel Coordination
We assist with e-Visa, flights, and accommodation in Cuba for the patient and accompanying family.
Treatment Cycle
Receive NeuralCIM neuroprotective therapy and intensive rehabilitation during your 4–8 week program.
Aftercare
Coordinated handover to your home physician with a long-term monitoring plan and remote follow-up.
NeuralCIM Questions & Answers
Important Medical Information
NeuralCIM is a Cuban biotechnology product that is not approved by the US Food and Drug Administration (FDA) and is not available in the United States. The information on this page is for educational purposes and does not constitute medical advice. NeuralCIM is not a cure for any neurological condition. Treatment outcomes vary and cannot be guaranteed. All treatment programs are individualized based on medical evaluation. Always consult with your physician before pursuing any medical treatment abroad.
Neurology & Neurorehabilitation
Request a Free Clinical Evaluation
Share your medical information with our neurology team and receive a personalized evaluation to determine if NeuralCIM neuroprotective therapy is suitable for your condition — often within 24–48 hours. No obligation, no travel required to get started.